The effect of combined delivery of recombinant human bone morphogenetic protein‐2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium‐phosphate‐coated implants on osseointegration
- 21 March 2011
- journal article
- Published by Wiley in Clinical Oral Implants Research
- Vol. 22 (12) , 1433-1439
Abstract
Objectives: The delivery of growth factors for enhanced osseointegration depends on the effectiveness of the carrier systems at the bone–implant interface. This study evaluated the effect of solo and dual delivery of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) and recombinant human vascular endothelial growth factor (rhVEGF165) from biomimetically octacalcium phosphate‐coated implants on osseointegration.Materials and methods: Biomimetic implants, bearing either a single growth factor (BMP or VEGF) or their combination (BMP+VEGF), were established, and compared with acid‐etched (AE, control) and biomimetic implants without growth factor (CAP). Implants were placed into frontal skulls of nine domestic pigs. The quality of osseointegration was evaluated using microradiographic and histomorphometric analysis of bone formation inside four defined bone chambers of the experimental implant at 1, 2 and 4 weeks.Results: Biomimetic implants, either with or without growth factor, showed enhanced bone volume density (BVD) values after 2 and 4 weeks. This enhancement was significant for the BMP and BMP+VEGF group compared with the control AE group after 2 weeks (PPConclusion: It was concluded that the combined delivery of BMP‐2 and VEGF enhances BVD around implants, but not BIC. Therefore, it may be assumed that changes in the surface characteristics should be considered when designing growth factor‐delivering surfaces.To cite this article: Ramazanoglu M, Lutz R, Ergun C, von Wilmowsky C, Nkenke E, Schlegel K A. The effect of combined delivery of recombinant human bone morphogenetic protein‐2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium‐phosphatecoated implants on osseointegration. Clin. Oral Impl. Res. xx, 2011; 000–000. doi: 10.1111/j.1600‐0501.2010.02133.xKeywords
This publication has 46 references indexed in Scilit:
- Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regenerationBiomaterials, 2009
- Bone healing at implants with a fluoride‐modified surface: an experimental study in dogsClinical Oral Implants Research, 2007
- Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogsClinical Oral Investigations, 2006
- Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell-Driven Bone RegenerationJournal of Bone and Mineral Research, 2005
- A systematic review of the influence of different titanium surfaces on proliferation, differentiation and protein synthesis of osteoblast‐like MG63 cellsClinical Oral Implants Research, 2004
- Influence of octacalcium phosphate coating on osteoinductive properties of biomaterialsJournal of Materials Science: Materials in Medicine, 2004
- Angiogenesis and bone repairDrug Discovery Today, 2003
- The biology of VEGF and its receptorsNature Medicine, 2003
- Biomimetic coatings on titanium: a crystal growth study of octacalcium phosphateJournal of Materials Science: Materials in Medicine, 2001
- A role for surface topography in creating and maintaining bone at titanium endosseous implantsThe Journal of Prosthetic Dentistry, 2000